ARCHIVES

Preoperative Drug Combo Benefits HER-2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

NIAID Names Tramont Director, Division Of AIDS.

July 20, 2001

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004